People with type 2 diabetes who meet inclusion criteria will be randomized to one of two treatment arms: Afrezza with One Drop | Premium – or – One Drop | Premium alone. Changes in hemoglobin A1C, quality of life, self-care, treatment satisfaction, and other metrics will be assessed.